Catheter-directed Sclerotherapy for Ovarian Endometrioma: Short-term Outcomes

Radiology
Kichang HanDo Yun Lee

Abstract

Purpose To evaluate the effectiveness of catheter-directed sclerotherapy (CDS) with 95% ethanol in patients with primary or recurrent ovarian endometriomas. Materials and Methods In this prospective study, 14 participants (mean age, 32 years; range, 20-44 years) who underwent CDS for ovarian endometrioma from March 2015 to December 2017 were evaluated. Diagnosis was based on symptoms and imaging studies. To assess the impact of CDS on ovarian reserve, serum anti-Müllerian hormone (AMH) was measured before CDS and 6 months after CDS. Serum cancer antigen 125 (CA-125) levels were also measured at the same time points. Follow-up US was performed 1, 3, and 6 months after CDS and biannually thereafter to monitor potential cyst size change and recurrence. Comparison of AMH, CA-125, and cyst size before and after CDS was performed by using the paired t test or Wilcoxon signed-rank test. Results Mean endometrioma size decreased from 5.8 cm ± 2.2 to 1.1 cm ± 1 (P ˂ .001). During a mean follow-up of 12.7 months (range, 6.1-23.0 months), there were no recurrences of endometrioma. Pain was relieved in all participants, with a decrease in serum CA-125 level (P = .001). There was no difference in serum AMH level before and 6 months after CDS...Continue Reading

References

Jun 1, 1997·Obstetrics and Gynecology Clinics of North America·B Eskenazi, M L Warner
Jan 9, 2001·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·J Noma, N Yoshida
Sep 25, 2002·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Toshimitsu KoikeIkuo Sato
Dec 25, 2002·Human Reproduction Update·Charles ChapronJean-Bernard Dubuisson
May 10, 2006·American Journal of Obstetrics and Gynecology·Mauro BusaccaMassimo Candiani
Jan 6, 2007·Cardiovascular and Interventional Radiology·Okan AkhanAli Ayhan
Feb 23, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Cihangir Mutlu ErcanIskender Baser
Aug 23, 2011·Ultrasound in Medicine & Biology·Lu-Lu WangSi-Ming Wang
Dec 1, 2010·Seminars in Interventional Radiology·Giustino Albanese, Kimi L Kondo
Jul 24, 2012·Fertility and Sterility·Richard O Burney, Linda C Giudice
Mar 5, 2015·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Amparo García-TejedorFernando Burdio
Nov 4, 2015·Archives of Gynecology and Obstetrics·Ming-Jun ShaoXiao-Jiu Xu
Jun 1, 2006·Journal of Medical Ultrasonics·Akiko IkutaHideharu Kanzaki
Jun 6, 2017·Fertility and Sterility·Aviad CohenTogas Tulandi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.